|
Transcripts that showed significantly increased expression in daf-2(e1370) neurons comparing to in N2 neurons at day 8adult stage. |
DESeq2, FDR < 0.05, fold change > 2. |
WBPaper00066978:daf-2(e1370)_upregulated_neuron
|
|
Transcripts that showed significantly increased expression in daf-16(mu86);daf-2(e1370) neurons comparing to in daf-2(e1370) neurons at day 8adult stage. |
DESeq2, FDR < 0.05, fold change > 2. |
WBPaper00066978:daf-16(mu86)_upregulated_neuron
|
|
Transcripts that showed altered expression in cat-2(RNAi) animals comparing to control animals injected with empty vector. |
p-value <= 0.05 |
WBPaper00066902:cat-2(RNAi)_regulated
|
|
Transcripts that showed significantly increased expression in lpd-3(ok2138) comparing to in N2 animals. |
DESeq2, fold change > 4, FDR < 0.05. |
WBPaper00064661:lpd-3(ok2138)_upregulated
|
|
Transcripts that showed significantly increased expression in ints-9(RNAi) comparing to in N2. |
DESeq2 and edgeR. |
WBPaper00056284:ints-9(RNAi)_upregulated
|
|
Transcripts that showed significantly increased expression in spc-1(cas971) comparing to in N2 at L1 larva stage. |
DESeq2, fold change >= 2, FDR <= 0.05 |
WBPaper00057041:spc-1(cas971)_upregulated
|
|
Transcripts of noncoding genes that showed significantly decreased expression in muscle. |
DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed. |
WBPaper00062325:muscle_depleted_noncoding-RNA
|